Robert Hershberg's Net Worth
$5.55 Million
Who is Robert Hershberg?
Robert Hershberg has an estimated net worth of $5.55 Million. This is based on reported shares across multiple companies, which include Adaptive Biotechnologies Corp, RECURSION PHARMACEUTICALS, INC., NanoString Technologies Inc, FATE THERAPEUTICS INC, Silverback Therapeutics, Inc., HilleVax, Inc., and DENDREON CORP.
SEC CIK
Robert Hershberg's CIK is 0001274139
Past Insider Trading and Trends
2020 was Robert Hershberg's most active year for acquiring shares with 23 total transactions. Robert Hershberg's most active month to acquire stocks was the month of May. 2020 was Robert Hershberg's most active year for disposing of shares, totalling 50 transactions. Robert Hershberg's most active month to dispose stocks was the month of January. 2020 saw Robert Hershberg paying a total of $212,004.96 for 191,217 shares, this is the most they've acquired in one year. In 2020 Robert Hershberg cashed out on 125,226 shares for a total of $2,419,425.59, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adaptive Biotechnologies Corp (ADPT) Snapshot price: $4.21
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +41.24% | 31.33K |
—
|
—
| 107.3K |
Mar 4
| |||
Form 4
| +24.14% | 14.78K |
—
|
—
| 75.97K |
Mar 6
| |||
Form 4
| +646.89% | 53K |
$0.45 | $23,850.00 | 61.19K |
Feb 2
| |||
Form 4
| +444.75% | 6.69K |
—
|
—
| 8.19K |
Jan 26
| |||
Form 4
|
—
|
0
|
$22.51 | -$88,220.00 |
0
|
Scheduled
|
Mar 8
| ||
Form 4
|
—
|
0
|
$22.51 | -$88,220.00 | 1.5K |
Scheduled
|
Mar 8
| ||
Form 4
|
∞
| 1.5K |
$32.95 | -$130,000.00 | 1.5K |
Scheduled
|
Feb 14 - Feb 16
| ||
Form 4
|
—
|
0
|
$33.51 | -$132,221.62 |
0
|
Scheduled
|
Jan 15
| ||
Form 4
|
—
|
0
|
$28.19 | -$110,956.43 |
0
|
Scheduled
|
Dec 15
| ||
Form 4
|
—
|
0
|
$24.07 | -$94,480.63 |
0
|
Scheduled
|
Nov 16
| ||
Form 4
|
—
|
0
|
$25.98 | -$102,120.00 |
0
|
Scheduled
|
Oct 15
| ||
Form 4
|
—
|
0
|
$21.52 | -$84,260.00 |
0
|
Scheduled
|
Sep 15
| ||
Form 4
|
—
|
0
|
$19.92 | -$77,870.51 |
0
|
Scheduled
|
Aug 17
| ||
Form 4
|
—
|
0
|
$22.15 | -$86,790.00 |
0
|
Scheduled
|
Jul 15
| ||
Form 4
|
—
|
0
|
$21.73 | -$85,096.72 |
0
|
Scheduled
|
Jun 15
| ||
Form 4
|
—
|
0
|
$17.60 | -$68,596.08 |
0
|
Scheduled
|
May 15
| ||
Form 4
|
—
|
0
|
$15.11 | -$733,000.00 |
0
|
Scheduled
|
Apr 23
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RECURSION PHARMACEUTICALS, INC. (RXRX) Snapshot price: $5.95
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +33.91% | 13.1K |
—
|
—
| 51.72K |
Jun 3
| |||
Form 4
| +48.49% | 12.61K |
—
|
—
| 38.62K |
Jun 16
| |||
Form 4
| +230.79% | 18.14K |
—
|
—
| 26.01K |
Jun 14
| |||
Form 4
| +9.67% | 693 |
—
|
—
| 7.86K |
Jan 3
| |||
Form 4
| +8.67% | 572 |
—
|
—
| 7.17K |
Oct 1
| |||
Form 4
| +5.55% | 347 |
—
|
—
| 6.6K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
| 6.25K |
Apr 20
| |||
Form 4
|
∞
| 6.25K |
—
|
—
| 6.25K |
Apr 15 - Apr 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NanoString Technologies Inc (NSTG) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +44.62% | 3.31K |
—
|
—
| 10.72K |
Apr 18
| |||
Form 4
| +292.06% | 5.52K |
—
|
—
| 7.41K |
Jun 15 - Jun 16
| |||
Form 4
|
—
|
0
|
$44.31 | -$8,524.14 | 1.89K |
Scheduled
|
Apr 15
| ||
Form 4
|
—
|
0
|
$39.07 | -$83,607.02 | 1.89K |
Scheduled
|
Mar 15
| ||
Form 4
|
—
|
0
|
$45.79 | -$82,172.94 | 1.89K |
Scheduled
|
Feb 16
| ||
Form 4
|
—
|
0
|
$41.91 | -$92,122.59 | 1.89K |
Scheduled
|
Jan 15
| ||
Form 4
|
—
|
0
|
$40.27 | -$87,194.40 | 1.89K |
Scheduled
|
Dec 15
| ||
Form 4
|
—
|
0
|
$28.94 | -$53,202.12 | 1.89K |
Scheduled
|
Nov 16
| ||
Form 4
|
—
|
0
|
$25.28 | -$42,219.03 | 1.89K |
Scheduled
|
Oct 15
| ||
Form 4
|
—
|
0
|
$27.41 | -$48,630.95 | 1.89K |
Scheduled
|
Sep 15
| ||
Form 4
|
—
|
0
|
$24.78 | -$40,754.58 | 1.89K |
Scheduled
|
Aug 17
| ||
Form 4
|
—
|
0
|
$23.67 | -$37,423.95 | 1.89K |
Scheduled
|
Jul 15
| ||
Form 4
|
∞
| 1.89K |
$20.99 | -$46,185.90 | 1.89K |
Scheduled
|
Jun 15 - Jun 16
| ||
Form 4
|
—
|
0
|
$19.15 | -$237,479.37 |
0
|
Scheduled
|
May 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FATE THERAPEUTICS INC (FATE) Snapshot price: $3.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +430.56% | 8.65K |
—
|
—
| 10.66K |
Jun 9
| |||
Form 4
| -25.07% | -672.00 |
$22.75 | -$15,288.00 | 2.01K |
Jun 3
| |||
Form 4
|
∞
| 2.68K |
—
|
—
| 2.68K |
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Silverback Therapeutics, Inc. (SPRY) Snapshot price: $11.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||